Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks
Kenvue Inc. (NYSE:KVUE) is included among the 10 Best NYSE Dividend Stocks to Buy.
Kenvue Inc. (NYSE:KVUE) produces and sells consumer health products across several categories, including over-the-counter medicines, personal care, and wellness items. Its portfolio features well-known household brands such as Tylenol for pain and fever relief, Neutrogena for skin care, and Listerine for oral hygiene.
Following its separation from Johnson & Johnson in 2023, Kenvue Inc. (NYSE:KVUE) has concentrated on using digital tools and consumer insights to strengthen brand relevance. At the same time, it is working to modernize its supply chain and ensure ongoing compliance with regulations. Recent initiatives highlight productivity improvements, stronger operating margins, and selective investments in digital marketing and product innovation.
After its separation from Johnson & Johnson, Kenvue Inc. (NYSE:KVUE) inherited the status of being recognized as a Dividend King. The company offers a quarterly dividend of $0.2075 per share, having raised it by 1.2% in July. With a dividend yield of 4.53%, as of September 20, KVUE is among the best dividend stocks on our list.
While we acknowledge the potential of KVUE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Best Dividend Paying Stocks to Buy Now and 13 Incredibly Cheap Dividend Stocks to Invest In.
Disclosure: None.
Content Original Link:
" target="_blank">
